Dow Down 0.25% Nasdaq Down 0.26%

Dyax Corp. (DYAX)

-NasdaqGM
10.02 0.18(1.76%) Aug 28, 4:00PM EDT
Prev Close:10.20
Open:10.12
Bid:7.01 x 100
Ask:10.71 x 100
1y Target Est:12.21
Beta:0.93
Earnings Date:Oct 20 - Oct 24 (Est.)
Day's Range:9.96 - 10.39
52wk Range:4.20 - 10.99
Volume:929,515
Avg Vol (3m):1,093,190
Market Cap:1.36B
P/E (ttm):N/A
EPS (ttm):-0.19
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
DYAXDown 1.76%1.36B
SHPG47.86B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):21.62
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.19
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:1.7
PEG Ratio (5 yr expected):-2.84

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dyax Corp., a biopharmaceutical company, identifies, develops, and commercializes treatments for hereditary angioedema (HAE) and plasma kallikrein-mediated (PKM) angioedemas. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback